Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

E Tacconelli, E Carrara, A Savoldi… - The Lancet infectious …, 2018 - thelancet.com
Background The spread of antibiotic-resistant bacteria poses a substantial threat to
morbidity and mortality worldwide. Due to its large public health and societal implications …

Analysis of the clinical antibacterial and antituberculosis pipeline

U Theuretzbacher, S Gottwalt, P Beyer… - The Lancet Infectious …, 2019 - thelancet.com
This analysis of the global clinical antibacterial pipeline was done in support of the Global
Action Plan on Antimicrobial Resistance. The study analysed to what extent antibacterial …

Lack of development of new antimicrobial drugs: a potential serious threat to public health

SR Norrby, CE Nord, R Finch - The Lancet infectious diseases, 2005 - thelancet.com
Antimicrobial resistance is threatening the management of infections such as pneumonia,
tuberculosis, malaria, and AIDS. In the past, resistance could be handled by development of …

The scope of the antimicrobial resistance challenge

IN Okeke, MEA de Kraker, TP Van Boeckel, CK Kumar… - The Lancet, 2024 - thelancet.com
Summary Each year, an estimated 7· 7 million deaths are attributed to bacterial infections, of
which 4.95 million are associated with drug-resistant pathogens, and 1· 27 million are …

Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance

R Laxminarayan, I Impalli, R Rangarajan, J Cohn… - The Lancet, 2024 - thelancet.com
The increasing number of bacterial infections globally that do not respond to any available
antibiotics indicates a need to invest in—and ensure access to—new antibiotics, vaccines …

Antibiotic resistance: global response needed

SJ Howard, M Catchpole, J Watson… - The Lancet Infectious …, 2013 - thelancet.com
In 1945, Sir Alexander Fleming famously warned of the danger of over-reliance on
antibiotics and the threat of bacteria developing resistance. 1 68 years later, his prediction …

The crisis of no new antibiotics—what is the way forward?

LJV Piddock - The Lancet infectious diseases, 2012 - thelancet.com
Antibiotic use not only underpins modern medicine, but has brought huge changes to the
world, especially in expectations of survival of children into adulthood. The theme of World …

Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options

A Zumla, ZA Memish, M Maeurer, M Bates… - The Lancet Infectious …, 2014 - thelancet.com
The emergence and spread of antimicrobial-resistant bacterial, viral, and fungal pathogens
for which diminishing treatment options are available is of major global concern. New viral …

The 10×'20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020

Infectious Diseases Society of … - Clinical Infectious …, 2010 - academic.oup.com
The time has come for a global commitment to develop new antibacterial drugs. Current data
document the impending disaster due to the confluence of decreasing investment in …

Alternatives to antibiotics—a pipeline portfolio review

L Czaplewski, R Bax, M Clokie, M Dawson… - The Lancet infectious …, 2016 - thelancet.com
Antibiotics have saved countless lives and enabled the development of modern medicine
over the past 70 years. However, it is clear that the success of antibiotics might only have …